Shares of DocuSign (NASDAQ: DOCU) dipped 20.2% in October, according to data provided by S&P Global Market Intelligence .
There wasn't any substantial negative news to alter the digital-signature company's outlook in the month, but its stock sold off in conjunction with a pullback for the broader market:
^SPX data by YCharts .
Docusign is a growth-dependent tech stock that saw big gains following its initial public offering in April, so shares pulling back amid a contraction for the broader market is somewhat to be expected. The stock also saw a double-digit price decline in September, following second-quarter results that left investors underwhelmed. But it's still up roughly 12% from market close on its first day of trading.
Image source: Getty Images.
While the rollout does not appear to have had a significant positive impact on the company's stock performance last month, DocuSign did launch a trial version of a service for signing and verifying home mortgage deals. DocuSign Rooms for Real Estate is expected to go into full release next spring, and will offer both partially digital and fully digital solutions for mortgage-document delivery and signings.
DocuSign is a leader in its niche, and has a large addressable market and impressive gross margin . It has avenues to becoming consistently profitable and expanding earnings, as it grows its customer base and adds new services. However, it could still face pricing pressure from competitors, and investors should proceed with the understanding that its offerings could be replicated by larger tech platforms.
DocuSign stock has posted gains in November, corresponding with positive movement for the broader market. Shares are trading up roughly 6% in the month so far:
^SPX data by YCharts .
The company's third quarter wrapped at the end of October, and management expects to report sales between $172 million and $175 million for the period. Full-year sales are expected to come in between $683 million and $688 million, with bookings coming in between $732 million and $752 million. Currently, shares trade at roughly 10 times this year's expected sales.
10 stocks we like better than DocuSign
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor , has quadrupled the market.*
David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and DocuSign wasn't one of them! That's right -- they think these 10 stocks are even better buys.
Click here to learn about these picks!
*Stock Advisor returns as of August 6, 2018
Keith Noonan has no position in any of the stocks mentioned. The Motley Fool recommends DocuSign. The Motley Fool has a disclosure policy .